Publication

p39, the Primary Activator for Cyclin-dependent Kinase 5 (Cdk5) in Oligodendroglia, Is Essential for Oligodendroglia Differentiation and Myelin Repair

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Andrew N. Bankston, Emory UniversityWenqi Li, Emory UniversityHui Zhang, Emory UniversityLi Ku, Emory UniversityGuanglu Liu, Emory UniversityFilomena Papa, University of KentuckyLixia Zhao, Emory UniversityJames A. Bibb, The University of Texas SouthwesternFranca Cambi, University of KentuckySeema K. Tiwari-Woodruff, University of California, Los AngelesYue Feng, Emory University
Language
  • English
Date
  • 2013-06-21
Publisher
  • American Society for Biochemistry and Molecular Biology
Publication Version
Copyright Statement
  • © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0021-9258
Volume
  • 288
Issue
  • 25
Start Page
  • 18047
End Page
  • 18057
Grant/Funding Information
  • Supported by National Institutes of Health Training Grant T32GM008602.
  • This work was supported, in whole or in part, by National Institutes of Health Grants NS053905 (to Y. F.), NS053905-03S2 (to F. C.), and MH083711, DA033485, and NS073855 (to J. A. B.). This work was also supported by National Multiple Sclerosis Society Grant NMSSRG 4010-A (to Y. F.) and an Emory University Research Committee grant (to Y. F.).
  • The FACS sorting facility at the University of Kentucky is supported in part by the National Institutes of Health Shared Instrument Program (S10 RR026827-01A1).
Abstract
  • Background: Cyclin-dependent kinase 5 (Cdk5) is crucial for brain development. Results: In contrast to neurons that utilize p35 as the primary Cdk5 activator, oligodendroglia employ p39-dependent Cdk5 activation to advance differentiation and myelin repair. Conclusion: p39 is the primary Cdk5 activator in oligodendroglia, essential for oligodendroglia development. Significance: Our study revealed distinct mechanisms controlling Cdk5 activity in neurons and oligodendroglia.
Author Notes
  • To whom correspondence should be addressed: Dept. of Pharmacology, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322. Tel.: 404-727-0351; Fax: 404-727-0365; E-mail: yfeng@emory.edu.
Keywords
Research Categories
  • Health Sciences, General
  • Biology, Molecular
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items